Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5619621 | Progress in Cardiovascular Diseases | 2017 | 30 Pages |
Abstract
Refractory recurrent pericarditis with corticosteroid dependence and colchicine resistance remain still an unsolved issue in search of new therapies, although old drugs such as azathioprine, intravenous immunoglobulins, and biological agents seem promising, but new randomized clinical trials are needed to confirm their role. Despite compromising the quality of life, idiopathic recurrent pericarditis has an overall good long-term outcome without mortality and significant risk of constrictive pericarditis evolution. The risk of constriction, the most feared complication, is related to the etiology and not the number of recurrences.
Keywords
NSAIDSMAD4IVIgHSVFMFCMRSTIRMEFVTNFCardiac magnetic resonanceEBVechocardiographyIntravenous immunoglobulinsinterleukinFamilial Mediterranean feverMediterranean feverDiagnosisTrapscomputed tomographyNon-steroidal anti-inflammatory drugsTherapyEtiologyLevel of evidencetumor necrosis factorLoEHBVHCVHepatitis C virushounsfield unithuman immunodeficiency virusHIVherpes simplex virushepatitis B virusC reactive proteinCRPPericarditisRecurrent pericarditisprognosis
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Massimo Imazio, Elena Gribaudo, Fiorenzo Gaita,